Valneva et IDT Biologika mettent fin à leur collaboration sur COVID-19 d’un commun accord
September 16, 2022 16:30 ET
|
VALNEVA
Saint-Herblain (France) et Dessau-Roßlau (Allemagne), le 16 septembre 2022 – Valneva SE (Nasdaq : VALN; Euronext Paris : VLA), société spécialisée dans les vaccins, et IDT Biologika ont annoncé...
Valneva publie ses résultats financiers du premier semestre 2022 et fait un point sur ses activités
August 11, 2022 01:00 ET
|
VALNEVA
Très bonne progression des programmes en développement clinique avancé Candidat vaccin contre la maladie de Lyme VLA15 Étude de Phase 3 initiée en août 20221Nouveaux résultats positifs de Phase...
Valneva Reports H1 2022 Results and Provides Corporate Updates
August 11, 2022 01:00 ET
|
VALNEVA
Excellent progress on late-stage clinical programs Lyme Disease Vaccine Candidate VLA15 Phase 3 study initiated in August 20221Further positive Phase 2 results reported, including first pediatric...
Prefilled Syringes Market by Therapeutic Area, Type of Syringe, Type of Material, Type of Molecule, and Key Geographical Regions : Industry Trends and Global Forecasts, 2022-2035
May 24, 2022 03:43 ET
|
ReportLinker
New York, May 24, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Prefilled Syringes Market by Therapeutic Area, Type of Syringe, Type of Material, Type of Molecule,...
IDT Corporation Acquires Leaf Global Fintech
March 14, 2022 16:30 ET
|
IDT Corporation
Innovative mobile wallet provider utilizes Stellar blockchain-powered solution to serve unbanked communities in East Africa NEWARK, NJ, March 14, 2022 (GLOBE NEWSWIRE) -- IDT Corporation...
IDT Corporation Reports Second Quarter Fiscal Year 2022 Results
March 07, 2022 16:33 ET
|
IDT Corporation
NEWARK, NJ, March 07, 2022 (GLOBE NEWSWIRE) -- IDT Corporation (NYSE: IDT), a global provider of fintech, cloud communications, and traditional communications services, today reported results for...
Valneva et IDT Biologika annoncent leur collaboration pour la production du vaccin inactivé contre la COVID-19, VLA2001
November 29, 2021 11:45 ET
|
VALNEVA
Saint-Herblain (France) et Dessau-Roßlau (Allemagne), le 29 novembre 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, et IDT Biologika ont annoncé...
Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2001
November 29, 2021 11:45 ET
|
VALNEVA
Saint-Herblain (France) and Dessau-Roßlau (Germany), November 29, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and IDT Biologika today announced their...
Global Vaccine Trade Gains Momentum, Surpassing $42B This Year - IndexBox
November 01, 2021 09:30 ET
|
IndexBox, Inc.
Los Angeles, CA, Nov. 01, 2021 (GLOBE NEWSWIRE) -- According to a new report published by market research firm IndexBox, in the first seven months of 2021, global vaccine exports were valued at...
Veterinary Vaccines Competitor Analysis Report - Global Forecast to 2026
September 24, 2021 09:16 ET
|
ReportLinker
New York, Sept. 24, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Veterinary Vaccines Competitor Analysis Report - Global Forecast to 2026" -...